Home > Insider Trading > Filing (0001213900-19-009297)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1697805	Xynomic Pharmaceuticals Holdings Inc.	XYN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1705781	Peixin Xu	Suite 3306, K. Wah Centre, 1010 Middle Huaihai Road Shanghai F4 200031		No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2019-05-15	108,980	$0.00	1,628,580	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Acquisiton	2019-05-15	25,000	$11.50	25,000	$11.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
225,937	2019-05-15	2024-05-15	No	4	P	Indirect

Footnotes

In connection with the closing of a business combination with Xynomic Pharmaceuticals, Inc. (the "Closing"), Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), (A) purchased 13,793 shares (the "Backstop Shares") of common stock of Bison Capital Acquisition Corp., a Delaware corporation (now known as Xynomic Pharmaceuticals Holdings, Inc., the "Company"), par value $0.001 per share pursuant to a Backstop and Subscription Agreement dated May 1, 2019 between the Company and Yiling Mark Xu; (B) converted its $500,000 promissory notes issued by the Company into 55,000 common shares and 25,000 warrants, each exercisable to purchase one share of common stock at $11.50 per whole share; and (C) received 40,187 common shares upon the exchange of its rights immediately outstanding prior to the Closing.
Pursuant to the promissory note and warrant agreement, each unit consists of one share; each whole warrant entitles the holder to one common share exercisable at $11.50 per share, expiring at the 5th anniversary of the Closing.
Fengyun Jiang, who has 100% ownership interest in Bison Capital and is Peixin Xu's spouse, has voting and dispositive power over the shares held by such entity. Mr. Xu was the Chairman of the Company but resigned at the closing of a business combination, effective May 15, 2019.